Exchange: NASDAQ·Updated 07:36 PM EDT
ATOS logo

ATOS Atossa Therapeutics Inc

$2.48
$0.02
(0.83%)
Today
Closed $2.44
$0.04
(1.64%)
After Hours
Reported EarningsAug 7
Mkt Cap$24.15M
Vol265,612.00

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
68

Bullish Sentiment

How do you feel about ATOS?

watatwit
$ATOS long post, IMO of course. After 6+ years of being long, not selling in 2021 and watching my investment being diluted due to malfeasance, I have taken a $15K loss and moved on. I was confidently bet this small amount on Endoxifen and its potential to treat breast cancer. My confidence in this drug is still there. My mistake was failing to be diligent when it comes to the executive leadership of Atossa. I do not believe Steven Quay has even the most remote of intentions to bring Endoxifen to market. I believe he is far more interested in funding his lifestyle as a scientist and padding his retirement off the backs of retail investors. I believe the revolving door of executives, legal counsel, PR reps, etc. is due to those people coming to the same conclusion.
10
The_Real_Heisenberg
$ATOS For the first time in a long long time, this stock closed well over 10%. The fact that it wasn't shorted down below it from that is, while not a sure sign, a pattern that only happens to a suppressed penny stock when MM has let off the brake pedals. Judging by the fact that Susquehanna exited their position, I'd say we're due for that easing of the brakes, and about to hit the gas. 10% movements attract more volume. This stock, with volume, has the potential to give 100% days with how low the market cap is, so get ready.
1
5
amsterplus
$ATOS Is this board dead like the company and its investors? Scumbag management cost me more than I would like to admit. They will continue to destroy the company and take the investors' last penny; however, leader quay has done quite well!
8
ncdorc
$ATOS The results of the Z-endoxifen 40 mg + abemaciclib 150 mg combination could determine the fate of Atossa.
6
Bunster
$ATOS FOLKS this is the real in and out.. When hes a bear hes right and righter .. when he switches to a bull he becomes wrong..
2
Bennythejet0901
$ATOS ive been in this since 2022, ive lost 90% of the money over the years with an average of 1.10 before r/s… yesterday i decided to let the last of what i had be sold. i wish you all luck and i hate to say this, but i hope quay goes bankrupt for all the corrupt shit he has done imo just to line his pockets with ATOS
7
ProfProfit
$ATOS Buy this garbage is BY FAR the worst financial decision I’ve ever made, and it may be the worst overall decision I’ve ever made because this is absolutely destroying any hopes I had of getting ahead, this will take me a decade to make back if I absolutely pull the plug on this and put it in some ETF where I onviously should have had it all along
7
NGCS
$ATOS I feel sorry for you folks. I was also invested here, but I told you 12 months ago that I took all my money from ATOS (with loss and very sad) and took it all to TVGN (bought at 6,48 average) and PGY (I sold this with 50% profit a weeks ago). Sincerely I am still with global loss because of ATOS, but I think I could recover some money in TVGN (IMO it is supposed to get 20 - 50 usd in 1 - 6 months, say, x3 minimum). NFA, it is only my DD. Please do yours.
1
4
NOYES
$ATOS too many deviations..Doc is justifying his hefty salary with conferences and business travels at the expense of RS and share holders...what is new here?
6
NOYES
$ATOS wasting money on travels for rare disease..whe the goal should be FdA approval/ progress
1
3
Bunster
$ATOS wtf is going on 225k volume 2.70 it may close over 3 are u kidding me /this is a wtf day
3
Bunster
$ATOS come on .3 DAYS AGO U SAID 3 PLUS BY FRIDAY!!!!!!!!!!!!OWN YOUR POSTS. AND BIG MISTAKES NOW ITS 2,20 AND BUY BUY BUY. PRIME TOLD THE BOARD MOST LIKELY NOT 3PLUS NOT HAPPENING..PRIME WAS RIGHT .. PEOPLE. LET PRIME EDUCATE U ONCE AGAIN.... PRAY THERE IS NO OFFERING ANNOUNCED LATE TODAY OE ON MONDAY.. GOT ITI!
1
ProfProfit
$ATOS taking this 20%+ gift and im out on half my shares. Absolutely brutal decision to make but obviously one i should have made long ago
4
Michaeljin_101
$ATOS Atossa Therapeutics CEO Steven Quay, M.D., Ph.D., published an article, in a new editorial, examines mammographic breast density as both a breast cancer risk factor and a measurable pharmacodynamic marker, and discusses findings from the Phase 2 KARISMA-Endoxifen trial of low-dose (Z)-endoxifen.
5
MaverickDragon
$ATOS to all the lads who have been bullish with me on this stock, check out $KBLB. Hoping to spread the cheer around !
5
Jbods11
$ATOS This feels like another Dr. Quay snake oil salesman moment. If anyone was around when they were trying to increase share count and he said they would never authorize the increase unless the share price hit $10 per share...well, that never materialized. Unfortunately, I have zero faith that this one materializes as well.
5
amsterplus
$ATOS Atossa's BoD abd Quay have certainly screwed investors royally. I hope they enjoyed cheating, lying (tis' the year for Atossa), essentially robbing investors and being outright maggots -info from Atossa has always been scarce but lately almost disappeared. Should have known it was fluff when Quay himself would not invest. Additionally, PR managers and CFOs appeared to be playing musical chairs. If a lawsuit is being considered, those would be the people that have the inside information.
5
RichardDangler
$ATOS my take - they know a buyer is not likely any time soon so a larger phase 3 is going to be needed. And to do so, they will need cash. Much more cash. With the warrants in place, they are going to try and thread the needle with positive end of year news to exercise those and raise cash there. Hopefully they do it into volume and buying to offset the damage. I still don’t think that will be enough cash, so likely another ATM raise will be needed, but I would assume by that point they’ve shown enough data to start generating interest. A possible bonus avenue (which I believe is their goal), is to use as little as capital as possible to advance their rare diseases enough to get to the point of a marketing application, and PRV. Then they would sell that, retain cash to fund phase 3, and issue the bonus to shareholders which should also generate more interest, and build the platform for future buyers, while phase 3 BC continues on. I think they have a plan…but let’s see.
4
The_Real_Heisenberg
$ATOS and yet.. it wasnt shorted back down. Thats a break in the pattern. MM has this stock on lock. It doesnt ever gain more than like 9.98% just barely below the 10%. This just kept rising today. I think its due for a correction up.
4
Seawolf32
$ATOS I don’t feel bad for anyone in here including myself. I’m down 86% and once had an 80 cent average. Do the math. Yeah complete garbage.
4

Advertisement|Remove ads.